On other hand, the beneficial effects observed in mouse models of stroke deserve to be developed at a human level considering the time frame of treatment of stroke and the fact that inhibiting eIF5A remains effective even 2 h after the brain injury, limiting the ischemic lesions and improving recovery of function. This evidence concerns the gene EIF5A and stroke disorder.